OR WAIT null SECS
Christen Harm is Pharmaceutical Executive's Associate Editor. Email her at charm@mmhgroup.com
September 01, 2019
Bristol-Myers Squibb’s cardiovascular development leader discusses the importance of diversifying clinical trials for better patient outcomes.